Mozambique’s third Census of Enterprises 2025-26 counted 140,807 entities, a 76% increase from the approximately 80,000 ...
In June 1933, the wife of a prominent McKeesport businessman, Robert Soles, was found dead of a gunshot wound. At first, ...
CLINICAL TRIALS – PHASE I & IIA First-in-human study design of VY1706, a systemically administered blood-brain barrier (BBB)-penetrant tau lowering gene therapy in early Alzheimer’s disease (#P055).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results